Article
5S clavam biosynthesis is controlled by an atypical two-component regulatory system in Streptomyces clavuligerus.
Antimicrobial agents and chemotherapy - 1 Sept 2012
Kwong Thomas, Zelyas Nathan J, Cai Hui, Tahlan Kapil, Wong Annie, Jensen Susan E
Abstract excerpt
Streptomyces clavuligerus produces a collection of five clavam metabolites, including the clinically important β-lactamase inhibitor clavulanic acid, as well as four structurally related metabolites called 5S clavams. The paralogue gene cluster of S. clavuligerus is one of three clusters of genes for the production of these clavam metabolites. A region downstream of the cluster was analyzed, and snk, res1, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
